Advanced Oncotherapy #AVO – GPSL Research on Advanced Oncotherapy Plc

       Free to access research and investor meetings in a post-MiFID2 world Advanced Oncotherapy (AVO-GB): Revamped particle therapy story Recommendation: OUTPERFORM (from NON-RATED) Target Price: 155p (from NIL) Current Price: 46p Click here for full PDF version KEY TAKEAWAY We upgrade AVO to OUTPERFORM with a fair value of 155 GBp. The company […]